Electroacupuncture inhibited neuronal apoptosis through PGAM5/FUNDC1-dependent mitophagy after ischemic stroke.

Researchers have discovered an important mechanism explaining how electroacupuncture (EA) helps protect the brain after stroke. When a stroke occurs, brain cells called neurons begin dying off through a process called apoptosis, which significantly impairs recovery and neurological function.

This study investigated how electroacupuncture works at the cellular level to prevent this neuronal death. Scientists found that EA activates a specialized cleanup process called mitophagy, which specifically removes damaged mitochondria—the energy-producing parts of cells. When mitochondria are damaged after stroke, they release harmful substances that trigger cell death.

The research revealed that electroacupuncture stimulates this protective cleanup through a specific molecular pathway involving two proteins: PGAM5 and FUNDC1. By activating this pathway, EA enhances the removal of damaged mitochondria, which reduces the production of harmful reactive oxygen species (ROS) and prevents the release of cytochrome c—both of which would otherwise trigger the death of neurons.

When researchers blocked this mitophagy process using a chemical inhibitor called 3-MA, the protective benefits of electroacupuncture were significantly reversed, confirming that this mechanism is essential to how EA provides neuroprotection.

What this means for patients: This research provides scientific evidence explaining why electroacupuncture is clinically effective for improving neurological function after ischemic stroke. The treatment appears to work by activating the brain's natural cellular cleaning mechanisms, helping preserve neurons that might otherwise die. This supports the use of electroacupuncture as part of stroke recovery protocols. If you're considering electroacupuncture for stroke recovery, seek treatment from a licensed acupuncturist with experience in neurological conditions.

This study elucidates the neuroprotective mechanism of electroacupuncture (EA) in ischemic stroke through PGAM5/FUNDC1-dependent mitophagy. Using an ischemic stroke model, researchers demonstrated that EA upregulates PGAM5 expression, which promotes FUNDC1 dephosphorylation and enhances FUNDC1-LC3 interaction, thereby activating mitophagy. This process selectively removes damaged mitochondria, reducing reactive oxygen species (ROS) production and cytochrome c release, ultimately inhibiting Caspase3 activation and neuronal apoptosis. EA treatment further upregulated FUNDC1 levels, amplifying the mitophagic response. Lateral ventricle injection of 3-methyladenine (3-MA), an autophagy inhibitor, significantly reversed EA's neuroprotective effects, confirming mitophagy as the primary mechanism. The study provides molecular evidence supporting EA's clinical efficacy in post-stroke recovery by demonstrating that neuronal preservation occurs through enhanced mitochondrial quality control rather than direct anti-apoptotic effects. Clinical takeaway: EA demonstrates significant neuroprotective potential in stroke management through activation of endogenous mitophagic pathways, supporting its integration into post-stroke rehabilitation protocols.